logo

Clovis Oncology, Inc. (CLVS)



Trade CLVS now with
  Date
  Headline
11/2/2017 12:04:41 PM RBC Capital Markets Is Cutting Clovis Oncology, Inc. (CLVS) 4Q17 Rev. Estimate To 20.9 M From 26.1 M
11/2/2017 12:04:19 PM RBC Capital Markets Is Raising Clovis Oncology, Inc. (CLVS) 2019 Estimate To -1.34 From -1.59
11/2/2017 12:03:58 PM RBC Capital Markets Is Increasing Clovis Oncology, Inc. (CLVS) 2018 Estimate To -3.84 From -4.19
11/2/2017 12:03:35 PM RBC Capital Markets Is Raising Clovis Oncology, Inc. (CLVS) 2017 Estimate To -7.65 From -7.79
11/2/2017 12:03:20 PM RBC Capital Markets Is Lowering Clovis Oncology, Inc. (CLVS) 2017 Rev. Estimate To 59.4 M From 68.6 M
10/25/2017 7:06:08 AM Sierra Oncology Appoints Andrew Allen To Its Board
7/31/2017 7:04:20 AM Bristol-Myers Squibb And Clovis Oncology Enter Clinical Collaboration Agreement
6/19/2017 4:03:10 PM Clovis Oncology Announces Proposed Offering Of Common Stock
6/19/2017 3:48:19 AM Clovis Oncology Says ARIEL3 Study Successfully Achieved Its Primary Endpoint
4/27/2017 7:12:02 AM Myriad Genetics And Clovis Oncology Sign Agreement For Use Of FDA-Approved BRACAnalysis CDx Test